5//SEC Filing
Novartis Institutes for BioMedical Research, Inc. 5
Accession 0000925421-19-000049
CIK 0001652130other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:02 PM ET
Size
10.1 KB
Accession
0000925421-19-000049
Insider Transaction Report
Form 5
Transactions
- Other
Common Stock
2018-05-16+25,074→ 4,302,147 total - Other
Common Stock
2018-06-18+25,074→ 4,327,221 total - Other
Common Stock
2018-07-16+25,074→ 4,352,295 total
Footnotes (2)
- [F1]Pro rata distribution from Atlas Venture Fund IX, L.P., of which Novartis Institutes for BioMedical Research, Inc. ("NIBRI") is a limited partner.
- [F2]The shares are held directly by NIBRI. NIBRI is an indirect wholly-owned subsidiary of Novartis AG.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001673852
Filing Metadata
- Form type
- 5
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:02 PM ET
- Size
- 10.1 KB